The first course of anti-aging treatment

Mr. G.C. received a course of anti-aging treatment at EmCell clinic.

Diagnosis: Aging. The involutional syndrome. Climax.

Tests:

• Average blood count: Erythrocytes 4.6x10¹²/l, Hb 154 g/l, color index 1.0, thrombocytes 210x10⁹/l, leukocytes 4.2x10⁹/l, stab neutrophils 3%, segmented neutrophils 56%, eosinophiles 4%, lymphocytes 23%, monocytes 4%, ESR 3 mm/hr.
• Chemistry: Bilirubin total 19.6 mmol/l, direct neg., indirect 19.6 mmol/l, ALT 0.38 mmol/l, ACT 0.24 mmol/l, thymol test 0.5 units, beta-lipoproteins 0.566, cholesterol 6.4 mmol/l, creatinine 0.065 mmol/l, albumin 72 g/l.
• Heart rate 66 bpm. Arterial pressure 110/70 mm Hg.
• EGC: Regular sinus rhythm. Signs of the diffuse changes in myocardium.

Mr. G.C. received a course of cell therapy. He was implanted human fetal cell suspensions of regenerative, rejuvenating, antiatherosclerotic and vascular action.

The 1st day of treatment. Transplantation of the sample 3038A583, injected intravenous dropwise, in the volume of 3.2 ml.
The 2nd day of treatment. Transplantation of the sample 3038A583, injected intravenous dropwise, in the volume of 2.8 ml.

The cell suspension samples 3038A583 possess the mentioned above functional activity and are certified as follows:

Bacterial sterility test	Negative
Prenatal diagnostic
Test with cardiolipid antigen	Negative
Anti - HIV1/HIV2	Negative
HBsAg	Negative
Fetal diagnosis
Enzygnost Anti - HIV1/HIV2	Negative
HBsAg monoclonal	Negative
Anti - HBc monoclonal	Negative
Anti - CMV/IgG+IgM	Negative
Anti - Rubella Virus/IgG	Negative
Varicella/Zoster	Negative
Toxoplasmosis/IgG	Negative

Mr. G.C. is recommended to repeat the course of the cell therapy in 9–12 months.